Dramatic response to intravitreal Bevacizumab in hypertensive retinopathy

Hypertensive retinopathy is seen frequently in patients with systemic hypertension and is usually asymptomatic. An acute rise in blood pressure may lead to exudative changes in the form of macular edema, hemorrhages, and serous macular detachment that can lead to visual decline. The authors report p...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Indian journal of ophthalmology 2018-10, Vol.66 (10), p.1494-1495
Hauptverfasser:	Padhy, Srikant, Kumar, Vinod
Format:	Artikel
Sprache:	eng
Schlagworte:	Angiogenesis Inhibitors - administration & dosage Bevacizumab Bevacizumab - administration & dosage Blood pressure Case Reports Case studies disc edema Dosage and administration Drug therapy Edema Female Fluorescein Angiography Fundus Oculi Humans Hypertension hypertensive retinopathy Hypertensive Retinopathy - diagnosis Hypertensive Retinopathy - drug therapy Immunotherapy Intravitreal Injections macular edema Monoclonal antibodies Ophthalmology Patients Permeability Receptors, Vascular Endothelial Growth Factor - antagonists & inhibitors Retina Retina - diagnostic imaging Retinal diseases Retinopathy serous macular detachment Tomography, Optical Coherence Treatment Outcome Visual Acuity Young Adult
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	Hypertensive retinopathy is seen frequently in patients with systemic hypertension and is usually asymptomatic. An acute rise in blood pressure may lead to exudative changes in the form of macular edema, hemorrhages, and serous macular detachment that can lead to visual decline. The authors report prompt resolution of exudative changes in a case of hypertensive retinopathy following intravitreal bevacizumab.
ISSN:	0301-4738 1998-3689
DOI:	10.4103/ijo.IJO_214_18